114 related articles for article (PubMed ID: 36400701)
1. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a potential prognostic factor in patients with gastric adenocarcinoma.
Alakuş H; Kaya M; Özer H; Eğilmez HR; Karadayı K
Arab J Gastroenterol; 2023 Feb; 24(1):5-10. PubMed ID: 36400701
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Variation of Lauren Classification in Gastric Cancer.
Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH
Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923
[TBL] [Abstract][Full Text] [Related]
3. Negative-to-Positive Lymph Node Ratio as an Independent Prognostic Factor for Gastric Adenocarcinoma.
Alakus H; Kaya M; Mollaoglu MC; Göksu M; Ozer H; Karadayi K
J Coll Physicians Surg Pak; 2021 Jul; 31(7):805-810. PubMed ID: 34271780
[TBL] [Abstract][Full Text] [Related]
4. Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis.
Pyo JH; Lee H; Min BH; Lee JH; Choi MG; Lee JH; Sohn TS; Bae JM; Kim KM; Yeon S; Jung SH; Kim JJ; Kim S
J Gastroenterol; 2017 May; 52(5):594-601. PubMed ID: 27590416
[TBL] [Abstract][Full Text] [Related]
5. Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy.
He H; Shen Z; Wang X; Qin J; Sun Y; Qin X
Jpn J Clin Oncol; 2016 Jan; 46(1):63-70. PubMed ID: 26497044
[TBL] [Abstract][Full Text] [Related]
6. Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.
Du CY; Chen JG; Zhou Y; Zhao GF; Fu H; Zhou XK; Shi YQ
World J Gastroenterol; 2012 Jul; 18(27):3610-6. PubMed ID: 22826628
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer.
Kawasaki Y; Ishigami S; Arigami T; Uenosono Y; Yanagita S; Uchikado Y; Kita Y; Nishizono Y; Okumura H; Nakajo A; Kijima Y; Maemura K; Natsugoe S
BMC Cancer; 2015 Jan; 15():5. PubMed ID: 25588809
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes after D2 gastrectomy for early gastric cancer: survival analysis of a single-center experience in China.
Wang Z; Ma L; Zhang XM; Zhou ZX
Asian Pac J Cancer Prev; 2014; 15(17):7219-22. PubMed ID: 25227817
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and availability of D2 lymph node dissection for the patients with stage II gastric cancer: comparative analysis of subgroups in stage II.
Park JM; Kim JH; Park SS; Kim SJ; Mok YJ; Kim CS
World J Surg; 2008 Jun; 32(6):1037-44. PubMed ID: 18347851
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
[TBL] [Abstract][Full Text] [Related]
11. Tumor volume as a prognostic factor was superior to the seventh edition of the pT classification in resectable gastric cancer.
Jiang N; Deng JY; Ding XW; Liu Y; Liang H
Eur J Surg Oncol; 2015 Mar; 41(3):315-22. PubMed ID: 25601610
[TBL] [Abstract][Full Text] [Related]
12. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
13. Effect of complication grade on survival following curative gastrectomy for carcinoma.
Jiang N; Deng JY; Ding XW; Zhang L; Liu HG; Liang YX; Liang H
World J Gastroenterol; 2014 Jul; 20(25):8244-52. PubMed ID: 25009399
[TBL] [Abstract][Full Text] [Related]
14. Is there any role of additional retropancreatic lymph node dissection on D2 gastrectomy for advanced gastric cancer?
Eom BW; Joo J; Kim YW; Park B; Park JY; Yoon HM; Lee JH; Ryu KW
Ann Surg Oncol; 2013 Aug; 20(8):2669-75. PubMed ID: 23543195
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
[TBL] [Abstract][Full Text] [Related]
16. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
17. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
18. Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer.
Sun YQ; Xie JW; Xie HT; Chen PC; Zhang XL; Zheng CH; Li P; Wang JB; Lin JX; Cao LL; Huang CM; Lin Y
World J Gastroenterol; 2017 Mar; 23(11):2012-2022. PubMed ID: 28373767
[TBL] [Abstract][Full Text] [Related]
19. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
Yildirim E; Celen O; Berberoglu U
J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920
[TBL] [Abstract][Full Text] [Related]
20. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.
Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Sima HR; Esmaili-Shandiz E; Hosseinnezhad H; Taghizadeh-Kermani A; Moaven O; Bahrani M
World J Gastroenterol; 2008 Nov; 14(41):6376-81. PubMed ID: 19009655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
